Target intelligence / Profile preview

Lysine methyltransferase 2C pseudogene 4 (KMT2CP4)

Target: KMT2CP4
Molecular classification: Pseudogene

Overview

Lysine methyltransferase 2C pseudogene 4 (KMT2CP4) is a non-coding pseudogene related by sequence to the KMT2C gene, which encodes a histone H3 lysine 4 methyltransferase involved in chromatin modification and enhancer function. KMT2CP4 is not thought to encode a functional protein and is not considered a therapeutic target or involved in disease. All descriptions of histone methylation activity, regulation, or disease associations pertain to the functional KMT2C (MLL3) gene, not to its pseudogenes.[1][3][5]

Other names: KMT2CP4

Beyond the preview

Go deeper on Lysine methyltransferase 2C pseudogene 4 (KMT2CP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysine methyltransferase 2C pseudogene 4 (KMT2CP4).

Explore the full profile